Patent Yard Sign in
Canadian application, no grantCanada

_-8-tetrahydro-cannabinol as antiemetic

CA 2136977 A1 · Owner: Abrahamov, Avraham · Inventors: Rapaport, Erich; Abrahamov, Avraham; Mechoulam, Raphael

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

An antiemetic pharmaceutical composition for use in conjunction with oncological chemitherapy. The composition is of special value in pediatric oncological medicine. The active ingredient is .DELTA.-8-tetrahydro-cannabinol .DELTA.-8-THC. Average unit do-, sage forms for use in pediatric medicine contain from about 4 mg/m2 to about 20 mg/m2 of the active compound.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 27, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 27, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 27, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 27, 1993
GrantedNo grant recorded
Term endedMay 27, 2013
Patent numberCA 2136977 A1
Classification (IPC)A61K31/35

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedMay 27, 1993Term endedMay 27, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.